Nature Biotechnology
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
✓ Free legal copy found
Preprint, hosted by National Institutes of Health (ncbi.nlm.nih.gov)
This is the authors’ own version from before peer review, so it may differ from the published paper.
Read it free at ncbi.nlm.nih.gov →DOI: 10.1038/nbt.3437 · Publisher: Springer Science and Business Media LLC